In the News

2/4/2016
Informex 2016: Fine Chemicals still upbeat as capacity moves back to US
IHS Chemical Week Magazine's Vincent Valk speaks with Johnson Matthey at Informex 2016.
1/25/2016
Johnson Matthey expands its R&D; and scale-up facilities in Cambridge, UK
Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has completed an expansion of its Cambridge, UK facilities.
1/22/2016
A Design of Experiments (DoE) Approach to Optimising APIs
In the December/January issue of Manufacturing Chemist magazine, Steve Collier, Director of R&D; and Manufacturing, Johnson Matthey Fine Chemicals, reviews recent DoE developments for improving process robustness and optimizing analytical method development.
11/3/2015
Global Business Report's interview with Garrett Dilley, Sr. Director, Business Development
Garrett Dilley, Senior Director, Business Development at Johnson Matthey Pharma Services in Devens, MA discusses Johnson Matthey's key role in the pharmaceutical manufacturing industry in the United States.
10/12/2015
Interview with John Fowler, Division Director, Johnson Matthey Fine Chemicals
John Fowler, Division Director of Johnson Matthey Fine Chemicals discusses the company's recent rebranding of its Fine Chemicals Division and strategic plans for the business.
10/2/2015
Johnson Matthey Named as Finalist for the CPhI Pharma Awards 2015
Johnson Matthey has been named a finalist for the CPhI Awards 2015 in the category of Best Innovation in Partnering and Outsourcing.
10/1/2015
Johnson Matthey acquires Pharmorphix
West Deptford, N.J. – 1st October, 2015 – Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has acquired the Pharmorphix® solid form research business from Sigma-Aldrich. This acquisition brings world-leading material science capabilities to Johnson Matthey’s expanding European API and clinical supply services.
9/15/2015
JM Fine Chemicals featured in Spec Chem Magazine Special US Supplement
Delivering what pharmaceuticals companies need requires a unique combination of specialist knowledge, internal and external collaboration and a strong heritage and foundation, as Johnson Matthey Fine Chemicals explains.
9/15/2015
Johnson Matthey rebrands its Fine Chemicals Division
West Deptford, N.J. – 15th September 2015 – Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has today unveiled the distinctive new branding for its Fine Chemicals Division.
3/17/2015
Johnson Matthey Receives Two Pharmaceutical and Biotech CMO Leaderships Awards 2015
Johnson Matthey has been recognised in the 2015 CMO Leadership Awards for the Reliability and Regulatory Track record of its Pharma Services to the Biotech Industry.
3/10/2015
Johnson Matthey Commissions New High Containment Manufacturing Capacity in Edinburgh, UK
Johnson Matthey has announced completion and commissioning of new high containment facilities for potent product manufacture at its Edinburgh, UK site (Macfarlan Smith).
2/24/2015
The Catalytic Reaction Guide App is now available!
The Catalytic Reaction Guide provides you with catalyst recommendations on over 150 reactions in the area of homogeneous, heterogeneous and asymmetric catalysis.
1/11/2011
Johnson Matthey Acquires Additional Manufacturing Facility
In November 2010, Johnson Matthey expanded its production capabilities by acquiring Riverside, a dedicated API manufacturing facility in Conshohocken, PA.